Annals of Oncology Advance Access published online on June 9, 2006
Annals of Oncology, doi:10.1093/annonc/mdl139
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Mayo Clinic College of Medicine, Hematology and Medical Oncology, Rochester, Minnesota, USA
* To whom correspondence should be addressed.
letter to the editor
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy
T. R. Halfdanarson 1 *,
S. N. Markovic 1,
U. Kalokhe 2,
and
M. Luppi 3
2 Oncology Center, Saint Margaret Mercy Healthcare Centers, Radiation Oncology, Hammond, Indiana, USA
3 Department of Oncology and Hematology. University of Modena, and Reggio Emilia, Modena, Italy
T. R. Halfdanarson, E-mail: halfdanarson.thorvardur{at}mayo.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz HIV-associated lymphomas and gamma-herpesviruses Blood, February 5, 2009; 113(6): 1213 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-B. Chen, A. Rahemtullah, and E. Hochberg Primary Effusion Lymphoma Oncologist, May 1, 2007; 12(5): 569 - 576. [Abstract] [Full Text] [PDF] |
||||

